SCHEMBL6830829

SCHEMBL6830829

O=P(O)(O)c1ccc(-c2nc3ccccc3n2-c2ccccc2)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.49
FBP1 P09467 12/20 0.48
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
PRKACA P17612 1/20 0.45
RPS6KB1 P23443 1/20 0.45
GSK3B P49841 1/20 0.45
ROCK1 Q13464 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAPKAPK2 P49137 1/20 0.43
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6829861 0.91 FBP1 (0.46) RECQLFBP1ESR1ESR2MAPK1
SCHEMBL6830819 0.86 FBP1 (0.44) FBP1MAPKAPK2
SCHEMBL6829871 0.86 FBP1 (0.44) FBP1HTTMAPKAPK2ALDH1A1KDM4E
SCHEMBL6829919 0.76 FBP1 (0.70) FBP1
SCHEMBL6830265 0.73 FBP1 (0.46) FBP1HTTRPS6KB1SMN1; SMN2MEN1
SCHEMBL6829940 0.72 EGFR (0.41) FBP1
SCHEMBL10814931 0.71 ALDH1A1 (0.61) RECQLESR1ESR2MAPK1HTT
SCHEMBL541157 0.69 ESR2 (0.78) RECQLESR1ESR2MAPK1HTT
SCHEMBL16280947 0.69 MAPK1 (0.65) RECQLESR1ESR2MAPK1HTT
SCHEMBL804992 0.69 ESR2 (0.73) RECQLESR1ESR2MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402895-A1 Benzimidazole inhibitors of fructose 1,6-biphosphatase Metabasis Therapeutics, Inc. (US) 2004-03-31 EP disclosed
EP-0970095-B1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE METABASIS THERAPEUTICS INC (US) 2003-10-29 EP disclosed
US-6399782-B1 ANTIDIABETIC AGENTS METABASIS THERAPEUTICS, INC. 2002-06-04 US disclosed
US-6110903-A INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE AT THE AMP SITE; ADMINISTERING TO TREAT DIABETES AND INHIBIT GLUCONEOGENESIS; 5-FLUORO-7-BROMO-1-ISOBUTYL-2-(2-PHOSPHONO-5-FURANYL) BENZIMIDAZOLE, FOR EXAMPLE SANKYO COMPANY LTD. (JP) 2000-08-29 US disclosed
EP-0970095-A1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE Metabasis Therapeutics, Inc. (US) 2000-01-12 EP disclosed
WO-1998039343-A9 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE 1999-01-21 WO disclosed
WO-1998039343-A1 NOVEL BENZIMIDAZOLE INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE METABASIS THERAPEUTICS, INC. (US) 1998-09-11 WO disclosed